Article: P.52 Newborn screening for Sickle Cell Disease in Brussels, a program with an ongoing clinical outcome improvement

Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer